Open Access

Cardiovascular risk reduction and lipid management: state of the science

Event: ESC CONGRESS 2016
Topic: Metabolism and metabolic syndromes
Session type: Satellite Symposium
Sponsored by Cleveland Clinic
Date: 29 August 2016
Time: 12:45 - 13:45

Congress Session

4 presentations in this session

Unmet medical needs with current agents and residual CV risk: rationale for developing new agents.

Speaker: Professor S. Nissen (Cleveland, US)
Thumbnail

New horizons for the statin intolerant patients: current and future therapeutic options.

Speaker: Doctor L. Cho (Cleveland, US)
Thumbnail

Prospects for clinical benefit with CETP inhibition in light of current and future trials.

Speaker: Professor A. Lincoff (Cleveland, US)
Thumbnail

The science of HDL and reverse cholesterol transport – Are we still hopeful?

Speaker: Professor J. Kastelein (Amsterdam, NL)
Thumbnail

4 speakers from this session

Professor Steven E Nissen

Cleveland Clinic Foundation, Cleveland (United States of America)
11 presentations
0 follower

Doctor Leslie Cho

Cleveland Clinic, Cleveland (United States of America)
14 presentations
0 follower

Professor A Michael Lincoff

Cleveland Clinic Foundation, Cleveland (United States of America)
6 presentations
0 follower

Professor John Kastelein

Faculty of Medecine - University of Amsterdam, Amsterdam (Netherlands (The))
21 presentations
1 follower

This platform is supported by

logo Novo Nordisk